Flora Hui
Might CRISPR gene editing in medicine open up a can of ‘unintended consequences’ worms? RNA advances could address that threat
The United States Food and Drug Administration has approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim ...